JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riviere, J. E.
Right arrow Articles by Rogers, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riviere, J. E.
Right arrow Articles by Rogers, R. A.

Decreased fractional renal excretion of gentamicin in subtotal nephrectomized dogs

JE Riviere, KF Bowman and RA Rogers

The purpose of this investigation was to determine the effects of subtotal surgical nephrectomy (three-quarters removal of renal mass) on the renal handling of gentamicin in the dog. Three and one-half months after surgery, dogs were anesthetized and steady-state clearances of gentamicin, creatinine, inulin and p-aminohippurate were determined. Subtotal nephrectomy proportionately decreased creatinine, inulin and p- aminohippurate clearances, but resulted in a significantly (P less than .05) decreased fractional excretion of gentamicin (0.97 +/- 0.24) (mean +/- S.D.) compared to intact dogs (1.22 +/- 0.08). Gentamicin serum protein binding by equilibrium dialysis was approximately 15% in both groups. In vitro canine cortical tissue slices accumulated drug as the slice/medium ratio was greater than one (1.77 +/- 0.47). This study indicates that the renal handling of gentamicin is altered in this disease model. This decreased fractional excretion of gentamicin implies that the quantity of drug excreted by the diseased kidney cannot be precisely predicted on the basis of glomerular filtration rate alone when drug dosage regimens are designed for patients with renal disease.

Volume 234, Issue 1, pp. 90-93, 07/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.